Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

170.69
+2.811.67%
Post-market: 170.65-0.0400-0.02%19:30 EDT
Volume:1.92M
Turnover:324.20M
Market Cap:22.91B
PE:-48.72
High:170.85
Open:167.25
Low:165.01
Close:167.88
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.71
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-102.78
PE(LYR):-51.41

Loading ...

Guardant Health Shares Climb Following Outlook Raise

Dow Jones
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 10.72% in Regular Trading, Q2 Revenue Significantly Beats Expectations with Full-Year Guidance Raised

Market Focus
·
Jul 31

RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Guardant Health is Maintained at Buy by BTIG

Dow Jones
·
Jul 31

Guardant Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Guardant Health Inc : RBC Raises Target Price to $200 from $185

THOMSON REUTERS
·
Jul 31

Movement Alert|Guardant Health Inc. Overnight Rise 5.67%, Q2 Revenue Significantly Beats Expectations with Full-Year Guidance Raised

Market Focus
·
Jul 31

Stock Track | Guardant Health Soars 5.67% in 24 Hours on Q2 Revenue Beat and Upbeat Full-Year Guidance

Stock Track
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 6.33% in After-Hours Trading, Q2 Revenue Beats Expectations and Full-Year Guidance Raised

Market Focus
·
Jul 31

Guardant Health files automatic mixed securities shelf

TIPRANKS
·
Jul 31

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS
·
Jul 31

Stock Track | Guardant Health Soars 7.65% in After-Hours Trading on Q2 Revenue Beat and Raised 2026 Guidance

Stock Track
·
Jul 31

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live
·
Jul 31

GUIDANCE: (GH) Guardant Health Now Expects Full Year 2026 Revenue Range $1.34B - $1.36B, vs. FactSet Est of $1.31B

MT Newswires Live
·
Jul 31

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings
·
Jul 31

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Reuters
·
Jul 31

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 5.02% in Regular Trading, Bristol-Myers Squibb Cancer Drug Beat Lifts Oncology Diagnostics Sector

Market Focus
·
Jul 31

Guardant Health to Present at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Jul 30

GH Research Initiated at Overweight by Wells Fargo

Dow Jones
·
Jul 27